Nxera Pharma Co., Ltd.
SOLTF
Price:
$6.185
Market Cap:
$91.55B
Nxera Pharma Co., Ltd. is a biopharmaceutical enterprise specializing in the development and global commercialization of pharmaceutical products. Operating across Japan, Switzerland, the United States, Bermuda, and the United Kingdom, the company provides a range of established treatments. Its current commercialized offerings include Ultibro/Breezhaler and Seebri/Breezhaler, both prescribed for chronic obstructive pulmonary disease, as well as Enerzair and Breezhaler, which are utilized in asthma management. Additionally, the portfolio features ORAVI, an innovative formulation for treating oropharyngeal candidiasis, and PIVLAZ, indicated for cerebral vasospasm. Looking to the future, Nxera P...[Read more]
Industry
Biotechnology
IPO Date
2013-09-04
Stock Exchange
OTC
Ticker
SOLTF
PE Ratio
[-7.11]
ROE
[-15.58%]
Current Ratio
[2.61]
Dividend Yield
[0%]
Enterprise Value
[135.78B]
Dividend History
The ROE as of June 2026 (TTM) for Nxera Pharma Co., Ltd. (SOLTF) is -15.58%
According to Nxera Pharma Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is -15.58%. This represents a change of 289.46% compared to the average of -4.00% of the last 4 quarters.
Nxera Pharma Co., Ltd. (SOLTF) Historical ROE (quarterly & annually)
How has SOLTF ROE performed in the past?
The mean historical ROE of Nxera Pharma Co., Ltd. over the last ten years is -2.05%. The current -15.58% ROE has changed 659.17% with respect to the historical average. Over the past ten years (40 quarters), SOLTF's ROE was at its highest in in the June 2016 quarter at 38.12%. The ROE was at its lowest in in the December 2025 quarter at -12.66%.
Average
-2.05%
Median
-2.39%
Minimum
-20.54%
Maximum
33.97%
Nxera Pharma Co., Ltd. (SOLTF) ROE by Quarter and Year
Discovering the peaks and valleys of Nxera Pharma Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 252.06%
Maximum Annual ROE = 33.97%
Minimum Annual Increase = -1732.88%
Minimum Annual ROE = -20.54%
| Year | ROE | Change |
|---|---|---|
| 2025 | -20.54% | 190.93% |
| 2024 | -7.06% | -34.42% |
| 2023 | -10.77% | -1732.88% |
| 2022 | 0.66% | -62.74% |
| 2021 | 1.77% | -37.32% |
| 2020 | 2.82% | -11.12% |
| 2019 | 3.18% | -116.62% |
| 2018 | -19.11% | 252.06% |
| 2018 | -5.43% | -115.99% |
| 2017 | 33.97% | -648.93% |
Nxera Pharma Co., Ltd. (SOLTF) Average ROE
How has SOLTF ROE performed in the past?
The current ROE of Nxera Pharma Co., Ltd. (SOLTF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-12.79%
5-year avg
-7.19%
10-year avg
-2.05%
Nxera Pharma Co., Ltd. (SOLTF) ROE vs. Peers
How is SOLTF’s ROE compared to its peers?
Nxera Pharma Co., Ltd.’s ROE is less than GenSight Biologics S.A. (42.20%), less than Basilea Pharmaceutica AG (27.95%), less than Viva Biotech Holdings (5.57%), less than MedinCell S.A. (84.89%), greater than 4DMedical Limited (-890.76%), greater than BioInvent International AB (publ) (-53.88%), greater than Race Oncology Limited (-47.44%), greater than Avacta Group Plc (-2929.47%), less than ManifestSeven Holdings Corporation (1.66%), less than JCR Pharmaceuticals Co., Ltd. (4.64%),
| Company | ROE | Market cap |
|---|---|---|
| 42.20% | $30.99M | |
| 27.95% | $746.00M | |
| 5.57% | $284.79M | |
| 84.89% | $1.23B | |
| -890.76% | $1.59B | |
| -53.88% | $216.40M | |
| -47.44% | $451.73M | |
| -2929.47% | $454.97M | |
| 1.66% | $1.71K | |
| 4.64% | $383.67M |
Build a custom stock screener for Nxera Pharma Co., Ltd. (SOLTF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nxera Pharma Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Nxera Pharma Co., Ltd. (SOLTF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Nxera Pharma Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Nxera Pharma Co., Ltd.'s ROE?
How is the ROE calculated for Nxera Pharma Co., Ltd. (SOLTF)?
What is the highest ROE for Nxera Pharma Co., Ltd. (SOLTF)?
What is the 3-year average ROE for Nxera Pharma Co., Ltd. (SOLTF)?
What is the 5-year average ROE for Nxera Pharma Co., Ltd. (SOLTF)?
How does the current ROE for Nxera Pharma Co., Ltd. (SOLTF) compare to its historical average?